Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Clinical Nutrition Market – Insights
Nutrition provides human beings with the required amount of proteins, carbohydrates, fats, water, vitamins, and minerals essential for proper cellular functioning and physiological activities and to maintain energy balance in the body. The clinical nutrition market is categorized on the basis of types as enteral nutrition, infant nutrition, and parenteral nutrition.
The global clinical nutrition market is estimated to account for US$ 48.6 Bn in terms of value in 2020 and is expected to reach US$ 66.2 Bn by the end of 2027.
Global Clinical Nutrition Market: Drivers
Increasing geriatric population is expected to propel growth of the global clinical nutrition market over the forecast period. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Moreover, high number of premature births is also expected to aid in growth of the market. For instance, according to the World Health Organization’s, February 2018 key facts, every year, an estimated 15 million infants s are born preterm worldwide.
Infant nutrition held dominant position in the global clinical nutrition market in 2019, accounting for 56.0% share in terms of value, followed by enteral nutrition and parenteral nutrition, respectively
Global Clinical Nutrition Market: Restraints
Stringent regulations and reimbursement issues are expected to hinder growth of the market. Clinical nutrition products are considered to be pharmaceutical products. Therefore, manufacturers need to follow certain set rules and regulations set by regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. and European Medicines Agency (EMA) in Europe. In the U.S., regulations for enteral products are quite different from those of parenteral products. Enteral products are similar to drugs, but they are not prescription drugs. Thus, they are not required to go through extensive clinical trials for safety and efficacy approvals before being marketed. Enteral nutrition products are governed by meticulous labeling requirements, including detailed supplement facts boxes. On the other hand, parenteral products are subject to more stringent testing and are effectively regulated in a manner similar to prescription drugs.
Moreover, lack of awareness of clinical nutrition in emerging economies is also expected to limit growth of the market.
Global Clinical Nutrition Market: Opportunities
Increasing demand for clinical nutrition in pediatric category is expected to offer lucrative growth opportunities for players in the market. This is attributed to high number of premature birth in emerging economies. For instance, according to the World Health Organization’s November 2018 release, the preterm births during 2014 was 13·4% in North Africa.
Opportunities – Increasing research and development in clinical nutrition
Moreover, R&D in clinical nutrition is also expected to aid in growth of the market. For instance, in March 2020, researchers from Agency for Science, Technology and Research and National University Health System, Singapore, reported comparing the effects of replacing 50% of total carbohydrate with soluble corn fiber or maltodextrin on the glycemic response and insulin response in the treatment of type 2 diabetes mellitus.
Market Trends/Key Takeaways
Increasing incidence of diabetes and obesity is boosting growth of the market. For instance, according to the Centers of Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2018, 71424.3 thousand people in the U.S. suffer from obesity. According to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
In the U.S., increasing healthcare expenditure is expected to propel growth of the market. For instance, according to the Centers for Medicare & Medicaid Services, health spending in the U.S. is projected to grow at an average rate of 5.5% per year for 2018-27 and to reach around US$ 6.0 trillion by 2027.
Global Clinical Nutrition Market: Competitive Landscape
Major players operating in the global clinical nutrition market include, Baxter International, Inc., Abbott Laboratories, B. Braun Melsungen AG, H. J. Heinz Company, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira, Inc., and Perrigo Company Plc.
Global Clinical Nutrition Market: Key Developments
Major players in the market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in October 2019, Groupe Danone partnered with The Food and Agriculture Organization of the United Nations to improve global nutrition and food safety knowledge, and promote responsible agricultural value chains for more sustainable food systems.